Legislation and Regulation
Friday, April 4, 2014
2:00 p.m. – 3:15 p.m.
AMGA Federal Legislative and Regulatory Update
Chester A. “Chet” Speed, JD, LLM, Vice President, Public Policy; Karen S. Ferguson, Senior Director for Public Policy; Christina Lavoie, JD, Director for Public Policy and Operations; and Garrett Eberhardt, Manager for Government Relations, American Medical Group Association
This panel discussion will provide an overview of AMGA’s healthcare agenda for Congress and the top issues affecting medical groups and health systems. Other topics to be covered include the latest on ACOs, Medicare Advantage, Medicare reform, including the sustainable growth rate, and healthcare current events, both legislative and regulatory.
Upon completion of this activity, participants should be able to describe legislative and regulatory issues that affect medical groups and health systems and AMGA’s advocacy efforts related to these issues.
Saturday, April 5, 2014
11:00 a.m. – 12:15 p.m.
Open Payments: Are You Ready?
John T. Randolph, Vice President and Chief Compliance Officer, UMass Memorial Health Care; Daniel Carlat, MD, Director, Prescription Project, The Pew Charitable Trusts; and Tara Shewchuk, Vice President, Ethics and Compliance, Medtronic, Inc.
On March 31, 2014, drug and device manufacturers must submit reports to the federal government detailing payments to all U.S. physicians and teaching hospitals, and this information will be publically published on September 30, 2014. Case studies will be shared to describe the publicity institutions can expect.
Upon completion of this activity, participants should be able to discuss how the Open Payments registry can cause negative publicity for health care institutions; apply effective policies from case studies of leading healthcare institutions to their organization; and list specific conflict of interest policies that may work for their institution.